1- Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk – a meta- analysis. Thyroid 2003;
                                                                                                                13(6): 585-93.
                                                                                                                2- Vestergaard P, Rejnmark L, Weeke J,Mosekilde L. Fracture risk in patients treated for hyperthyroidism . Thyroid
                                                                                                                2000; 10(4): 341-8.
                                                                                                                3- Hallengren B, Elmstahi B, Berglund J, Christensen B,Elmstahl S,Johnell O,et al. No increase in fracture
                                                                                                                incidence in patients treated for thyrotoxicosis in Malmo during 1970-74. A20- year population – based follow-up. J
                                                                                                                Intern Med 1999; 246: 139-144.
                                                                                                                4- Diamond T, Vine J, Smart R, Butler P. Throtoxic bone disease in women: A potentially reversible disorder. Ann
                                                                                                                Intern Med 1994; 120: 8-11.
                                                                                                                5- Toh SH, Claunch BC, Brown PH. Effect of hyperthyroidism and its treatment on bone mineral content. Arch
                                                                                                                Intern Med 1985; 145: 883-886.
                                                                                                                6- Oikawa M, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, et al. Bone turn over and cortical bone
                                                                                                                mineral density in the distal radius in patients with hyperthyroidism being treated with anti thyroid drugs for various
                                                                                                                periods of time . Clin Endocrinol 1999; 50: 171- 176.
                                                                                                                7- Ohishi T, Kushida K, Takahashi M, Kawana M, Yagi K, Kawakami K, et al. Urinary bone resorption markers in
                                                                                                                patients with metabolic bone disorders. Bone 1994; 15: 15-20.
                                                                                                                8- Cumming SR , Nevitt MC , Browser WS , Stone K, Fox KM , Ensrude KE, et al. Risk factors for hip fracture
                                                                                                                in white women. N Engl J Med 1995; 332: 767- 73.
                                                                                                                9- Wejda B , Hintze G , Katschinskibn B ,Olbricht T, Benker G. Hip fractures and the thyroid : a case – control
                                                                                                                study . J Intern Med 1995; 237: 241-47.
                                                                                                                10- Foldes J, Tarjar G, Szathmari M, Varga F, Krasznai I, Horvath CS. Bone mineral density in patients with
                                                                                                                endogenous sub clinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis? Clin Endocrinol 1993;
                                                                                                                39: 521- 527.